Mather Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18K Buy
1,317
+811
+160% +$11.1K ﹤0.01% 1472
2026
Q2
$6.86K Hold
506
– – ﹤0.01% 1568
2026
Q1
$3.03K Buy
+506
New +$3.81K ﹤0.01% 1649
2025
Q4
– Sell
-618
Closed -$6.6K – 1331
2025
Q3
$6.6K Buy
+618
New +$6.06K ﹤0.01% 1339
2025
Q2
– Sell
-4,248
Closed -$63.3K – 1365
2025
Q1
$63.3K Sell
4,248
-976
-19% -$15K ﹤0.01% 857
2024
Q4
$77.9K Sell
5,224
-781
-13% -$12.7K ﹤0.01% 785
2024
Q3
$115K Sell
6,005
-2,255
-27% -$46.7K ﹤0.01% 707
2024
Q2
$155K Buy
8,260
+865
+12% +$17.2K ﹤0.01% 682
2024
Q1
$107K Buy
+7,395
New +$127K ﹤0.01% 688

Other funds holding OGN

Mather Group's OGN Position: Q3 2026 in Review

Mather Group increased its Organon & Co (OGN) stake by 160% in Q3 2026, buying an estimated $11.1K and bringing the position to 1,317 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1472.

Mather Group first reported a position in OGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $155K in Q2 2024. 90 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Mather Group held 1,317 shares of Organon & Co worth $18K as of Q3 2026.
  • Mather Group bought 811 Organon & Co shares in Q3 2026, an estimated $11.1K.
  • Organon & Co made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1472 holding.
  • Mather Group first reported a position in Organon & Co in Q1 2024 and has held it in 9 quarters since.
  • Mather Group's Organon & Co position peaked at $155K in Q2 2024.
  • 90 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.